therefore, it is too early to predict if GLP-1s will provide benefit for patients with these conditions
Most healthy people can meet their nutritional needs through a balanced diet
Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, et al
There was also lower rates of fibrosis progression in the liraglutide group as compared to placebo
However, we also recognize that for some patients, particularly those managing conditions like type 2 diabetes, obesity-related sleep apnea, or other metabolic challenges, medication can be a vital tool on the path to better health
Back US FDA (Dec 2017) 'Drug Trial Snapshot: Ozempic'